Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
8 "Joonyub Lee"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Editorial
Diabetes, obesity and metabolism
Exploring Sex-Specific Mechanisms in Type 2 Diabetes Mellitus by Single-Cell Analysis in Pancreatic Islets
Joonyub Lee
Endocrinol Metab. 2025;40(5):699-701.   Published online October 29, 2025
DOI: https://doi.org/10.3803/EnM.2025.2678
  • 937 View
  • 25 Download
PDFPubReader   ePub   
Close layer
Review Article
Diabetes, obesity and metabolism
Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia
Joonyub Lee, Kun-Ho Yoon
Endocrinol Metab. 2025;40(1):57-63.   Published online January 15, 2025
DOI: https://doi.org/10.3803/EnM.2024.2193
  • 6,671 View
  • 200 Download
  • 3 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
In East Asians, type 2 diabetes mellitus (T2DM) is primarily characterized by significant defects in insulin secretion and comparatively low insulin resistance. Recently, the prevalence of T2DM has rapidly increased in East Asian countries, including Korea, occurring concurrently with rising obesity rates. This trend has led to an increase in the average body mass index among East Asian T2DM patients, highlighting the influence of insulin resistance in the development of T2DM within this group. Currently, the incidence of T2DM in Korea is declining, which may indicate potential adaptive changes in insulin secretory capacity. This review focuses on the changing epidemiology of T2DM in East Asia, with a particular emphasis on the characteristics of peak functional β-cell mass.

Citations

Citations to this article as recorded by  
  • Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial
    Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha
    Diabetes, Obesity and Metabolism.2026; 28(1): 728.     CrossRef
  • A phase 1 single and multiple ascending dose study of orforglipron in Japanese participants with type 2 diabetes
    Kenji Ohwaki, Chino Nakamura, Risa Nasu, Kazumasa Takenouchi, Tetsuaki Hirase
    Journal of Diabetes Investigation.2026; 17(2): 205.     CrossRef
  • Association between the triglyceride-glucose index and risk of type 2 diabetes mellitus and the mediating effect of BMI: a comparative analysis in Chinese and Japanese populations
    Yuxian Chen, Haiyong Zeng, Ziqi Luo, Haofei Hu, XinYu Wang
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Anti-Diabetic Potential of Corn (Zea mays L.) Silk: A Systematic Review and Meta-Analysis of Preclinical Studies
    Bohari Bohari, Rimbawan Rimbawan, Zuraidah Nasution, Ekowati Handharyani
    Preventive Nutrition and Food Science.2026;[Epub]     CrossRef
  • Association of Insulin Resistance with Dysglycemia in Elder Koreans: Age- and Sex-Specific Cutoff Values
    Sang Min Yoon, Boyoung Park
    Journal of Personalized Medicine.2025; 15(9): 438.     CrossRef
  • Exploring Sex-Specific Mechanisms in Type 2 Diabetes Mellitus by Single-Cell Analysis in Pancreatic Islets
    Joonyub Lee
    Endocrinology and Metabolism.2025; 40(5): 699.     CrossRef
Close layer
Original Articles
Miscellaneous
Lipid Variability Induces Endothelial Dysfunction by Increasing Inflammation and Oxidative Stress
Marie Rhee, Joonyub Lee, Eun Young Lee, Kun-Ho Yoon, Seung-Hwan Lee
Endocrinol Metab. 2024;39(3):511-520.   Published online May 16, 2024
DOI: https://doi.org/10.3803/EnM.2023.1915
  • 6,551 View
  • 150 Download
  • 24 Web of Science
  • 25 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigates the impact of fluctuating lipid levels on endothelial dysfunction.
Methods
Human aortic and umbilical vein endothelial cells were cultured under varying palmitic acid (PA) concentrations: 0, 50, and 100 μM, and in a variability group alternating between 0 and 100 μM PA every 8 hours for 48 hours. In the lipid variability group, cells were exposed to 100 μM PA during the final 8 hours before analysis. We assessed inflammation using real-time polymerase chain reaction, Western blot, and cytokine enzyme-linked immunosorbent assay (ELISA); reactive oxygen species (ROS) levels with dichlorofluorescin diacetate assay; mitochondrial function through oxygen consumption rates via XF24 flux analyzer; and endothelial cell functionality via wound healing and cell adhesion assays. Cell viability was evaluated using the MTT assay.
Results
Variable PA levels significantly upregulated inflammatory genes and adhesion molecules (Il6, Mcp1, Icam, Vcam, E-selectin, iNos) at both transcriptomic and protein levels in human endothelial cells. Oscillating lipid levels reduced basal respiration, adenosine triphosphate synthesis, and maximal respiration, indicating mitochondrial dysfunction. This lipid variability also elevated ROS levels, contributing to a chronic inflammatory state. Functionally, these changes impaired cell migration and increased monocyte adhesion, and induced endothelial apoptosis, evidenced by reduced cell viability, increased BAX, and decreased BCL2 expression.
Conclusion
Lipid variability induce endothelial dysfunction by elevating inflammation and oxidative stress, providing mechanistic insights into how lipid variability increases cardiovascular risk.

Citations

Citations to this article as recorded by  
  • NLRP3 inhibition protects human coronary endothelial cells from oxidative and lipotoxic stress
    Astrid Parenti, Costanza Titi, Arianna Brovero, Federica Blua, Francesca Boccato, Angela Silvano, Francesco Fedele, Anna Vittoria Mattioli, Massimo Bertinaria, Pasquale Pagliaro, Claudia Penna
    Biochemical Pharmacology.2026; 244: 117615.     CrossRef
  • Lipid dysregulation in renal cancer: Drivers of tumor growth and determinants of treatment-induced toxicity
    Mohammed Alnukhali, Alessia Fornoni, Alan Pollack, Anis Ahmad
    Seminars in Cancer Biology.2026; 119: 54.     CrossRef
  • Mitochondrial Dysfunction in Inflammatory Skin Diseases: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies
    Mei Li, Guowei Zhao, Guo‐wei Zhao, Jie Shen
    Drug Development Research.2026;[Epub]     CrossRef
  • A Review of Emerging Biomarkers Connecting Diabetes and Ischemic Stroke: Implications for Early Detection and Risk Stratification
    Nadia Hussain, Azza Ramadan, Amal Hussain Ibrahim Al Haddad, Zina Alfahl, Kenneth Lo
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • Roles of Catecholamines and Inflammation in Endothelial Dysfunction: a Study Using Takotsubo Syndrome Patient-specific hiPSC-ECs
    Guoqiang Yang, Luyi Zhong, Jiayue Wang, Chenyu Yang, Lukas Cyganek, Nazha Hamdani, Xiaobo Zhou, Xuehui Fan, Ibrahim El-Battrawy, Ibrahim Akin
    Stem Cell Reviews and Reports.2026;[Epub]     CrossRef
  • Emerging regulators of endothelial lipid metabolism in atherosclerosis
    Jason S. Irei, Kai Hirayama, William A. Boisvert
    Current Opinion in Lipidology.2026;[Epub]     CrossRef
  • Association between triglyceride glucose index-related indices and kidney stones in adults based on NHANES 2007–2020
    Ming Liu, Ping Yang, Yunpeng Gou
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The Impact of Modifiable Risk Factors on the Endothelial Cell Methylome and Cardiovascular Disease Development
    Hashum Sum, Alison C. Brewer
    Frontiers in Bioscience-Landmark.2025;[Epub]     CrossRef
  • A retrospective study on the correlation between antibody levels and endothelial function in SLE patients: An analysis based on ultrasound and serum biomarkers
    Huan Xia, Zaixing Pan, Yun Hong, Qingzhu Zhao, Weili Fan
    Molecular Immunology.2025; 181: 66.     CrossRef
  • Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
    Hygerta Berisha, Reham Hattab, Laura Comi, Claudia Giglione, Silvia Migliaccio, Paolo Magni
    Nutrients.2025; 17(5): 776.     CrossRef
  • Mitochondria‑derived peptides: Promising microproteins in cardiovascular diseases (Review)
    Yutong Ran, Zhiliang Guo, Lijuan Zhang, Hong Li, Xiaoyun Zhang, Xiumei Guan, Xiaodong Cui, Hao Chen, Min Cheng
    Molecular Medicine Reports.2025; 31(5): 1.     CrossRef
  • Long-term cardiovascular risk and mortality associated with uric acid to HDL-C ratio: a 20-year cohort study in adults over 40
    Ying Cui, Wen Zhang
    Scientific Reports.2025;[Epub]     CrossRef
  • Dapagliflozin prevents vascular ischemia-reperfusion injury in healthy young males: a randomized, placebo-controlled, double-blinded trial
    Martin Lutnik, Stefan Weisshaar, Brigitte Litschauer, Michaela Bayerle-Eder, Jan Niederdöckl, Michael Wolzt
    Scientific Reports.2025;[Epub]     CrossRef
  • Crucial roles of calcium ATPases and phosphoinositides: Insights into pathophysiology and therapeutic strategies
    Hyun-Oh Gu, Seung Wan Noh, Ok-Hee Kim, Byung-Chul Oh
    Molecules and Cells.2025; 48(9): 100254.     CrossRef
  • Endothelial dysfunction in atherosclerosis: from classical pathways to emerging mechanisms
    Yuyao Feng, Chenyang Li, Junye Chen, Xingqi Xiao, Qilong Mao, Hongmei Zhao, Jing Wang, Bao Liu
    Vessel Plus.2025;[Epub]     CrossRef
  • RNF213-Related Vasculopathy: An Entity with Diverse Phenotypic Expressions
    Takeshi Yoshimoto, Sho Okune, Shun Tanaka, Hiroshi Yamagami, Yuji Matsumaru
    Genes.2025; 16(8): 939.     CrossRef
  • Comparative hepatotoxicity of HFPO-TA and PFOA in Opsariichthys bidens: Greater liver injury induced by the PFOA alternative
    Zhenlan Xu, Zhengzheng Liu, Tao Tang, Dou Wang, Lu Lv, Jinsong Liu, Xinquan Wang, Yanhua Wang
    Environmental Pollution.2025; 386: 127216.     CrossRef
  • Advances in Mitochondrial Dysfunction and Its Role in Cardiovascular Diseases
    Yan Qiu, Shuo Chang, Ye Zeng, Xiaoqi Wang
    Cells.2025; 14(20): 1621.     CrossRef
  • The Systemic Link Between Oral Health and Cardiovascular Disease: Contemporary Evidence, Mechanisms, and Risk Factor Implications
    Florinel Cosmin Bida, Florin Razvan Curca, Raoul-Vasile Lupusoru, Dragos Ioan Virvescu, Mihaela Scurtu, Gabriel Rotundu, Oana Maria Butnaru, Teona Tudorici, Ionut Luchian, Dana Gabriela Budala
    Diseases.2025; 13(11): 354.     CrossRef
  • Extra Virgin Olive Oil (EVOO) Improves Vascular Endothelial Function and Hemodynamic Parameters in Patients with Hyperlipidemia: A Post Hoc Analysis of a Randomized Controlled Trial
    Christos Kourek, Emmanouil Makaris, Vassiliki Benetou, Prokopios Magiatis, Virginia Zouganeli, Stavros Dimopoulos, Georgios Georgiopoulos, Alexandros Briasoulis, Ioannis Paraskevaidis, Eleni Melliou, Philippos Orfanos
    Nutrients.2025; 17(23): 3650.     CrossRef
  • Peripheral artery disease and local drug delivery: a review of disease pathology and drug delivery systems for therapy below the knee
    Nicole M. Akers, Tammy R. Dugas
    Experimental Biology and Medicine.2025;[Epub]     CrossRef
  • Palmitic but Not Oleic Acid Induces Pro-Inflammatory Dysfunction of Human Endothelial Cells from Different Vascular Beds In Vitro
    Daria Shishkova, Victoria Markova, Yulia Yurieva, Alexey Frolov, Anastasia Lazebnaya, Maxim Sinitsky, Anna Sinitskaya, Vera Matveeva, Evgenia Torgunakova, Alexander Stepanov, Anna Malashicheva, Asker Khapchaev, Nikita Podkuychenko, Alexander Vorotnikov, V
    International Journal of Molecular Sciences.2025; 26(24): 12148.     CrossRef
  • Can Daily Dietary Choices Have a Cardioprotective Effect? Food Compounds in the Prevention and Treatment of Cardiometabolic Diseases
    Elżbieta Szczepańska, Barbara Janota, Marika Wlazło, Magdalena Gacal
    Metabolites.2024; 14(6): 296.     CrossRef
  • Lipid Swings Provoke Vascular Inflammation
    Jae-Han Jeon
    Endocrinology and Metabolism.2024; 39(3): 448.     CrossRef
  • Relationship between Oral Lichen Planus and Cardiovascular Disease of Atherosclerotic Origin: Systematic Review and Meta-Analysis
    Beatriz Gonzalez Navarro, Sonia Egido Moreno, Carlos Omaña Cepeda, Albert Estrugo Devesa, Enric Jane Salas, Jose Lopez Lopez
    Journal of Clinical Medicine.2024; 13(16): 4630.     CrossRef
Close layer
Diabetes, obesity and metabolism
Effectiveness of a Social Networking Site Based Automatic Mobile Message Providing System on Glycemic Control in Patients with Type 2 Diabetes Mellitus
Kyuho Kim, Jae-Seung Yun, Joonyub Lee, Yeoree Yang, Minhan Lee, Yu-Bae Ahn, Jae Hyoung Cho, Seung-Hyun Ko
Endocrinol Metab. 2024;39(2):344-352.   Published online December 27, 2023
DOI: https://doi.org/10.3803/EnM.2023.1871
  • 5,318 View
  • 132 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigated the effectiveness of a social networking site (SNS)-based automatic mobile message providing system on glycemic control in patients with type 2 diabetes mellitus (T2DM).
Methods
A 3-month, randomized, open-label, controlled, parallel-group trial was conducted. One hundred and ten participants with T2DM were randomized to a mobile message system (MMS) (n=55) or control group (n=55). The MMS group received protocolbased automated messages two times per day for 10 weeks regarding diabetes self-management through KakaoTalk SNS messenger. The primary outcome was the difference in the change in glycated hemoglobin (HbA1c) levels (%) from baseline to week 12.
Results
HbA1c levels were more markedly decreased in the MMS group (8.4%±0.7% to 8.0%±1.1%) than in the control group (8.5%±0.8% to 8.4%±0.8%), resulting in a significant between-group difference (P=0.027). No differences were observed in changes in fasting glucose levels, lipid profiles, and the number of participants who experienced hypoglycemia, or in changes in lifestyle behavior between groups. However, the self-monitoring of blood glucose frequency was significantly increased in the MMS group compared to the control group (P=0.003). In addition, sleep duration was increased in the MMS group, but was not changed in the control group.
Conclusion
An SNS-based automatic mobile message providing system was effective in improving glycemic control in patients in T2DM. Studies which based on a more individualized protocol, and investigate longer beneficial effect and sustainability will be required in the future.

Citations

Citations to this article as recorded by  
  • Text messaging interventions are associated with reductions in HbA1c among patients with diabetes: a systematic review and meta-analysis
    Neda Pirouzmand, Grace S Ko, Lucas C Godoy, Olivia Haldenby, Cynthia A Jackevicius, Ayman Jubran, Candace D McNaughton, Baiju R Shah, Maneesh Sud, Karen Tu, Dennis T Ko
    BMJ Open Diabetes Research & Care.2025; 13(6): e005218.     CrossRef
  • Effectiveness of text message-delivered health behaviour intervention on HbA1c change in adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials
    Qiumian Hong, Xiaoying Zhang, Mengxi Guo, Zhaoyang Wen, Qing Tang, Jiali Zhou, Peige Song, Xiaolin Wei, Ning Zhang
    Health Psychology Review.2025; : 1.     CrossRef
  • Effects of multimodal mobile health interventions on cardiovascular risk factor management in patients with diabetes: a systematic review and meta-analysis
    Yan Zhang, Xingqi Cao, LiJuan Huang, Yue Zhu, Liying Chen
    BMJ Open.2025; 15(12): e108371.     CrossRef
Close layer
Miscellaneous
Prediction of Cardiovascular Complication in Patients with Newly Diagnosed Type 2 Diabetes Using an XGBoost/GRU-ODE-Bayes-Based Machine-Learning Algorithm
Joonyub Lee, Yera Choi, Taehoon Ko, Kanghyuck Lee, Juyoung Shin, Hun-Sung Kim
Endocrinol Metab. 2024;39(1):176-185.   Published online November 21, 2023
DOI: https://doi.org/10.3803/EnM.2023.1739
  • 5,132 View
  • 139 Download
  • 5 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Cardiovascular disease is life-threatening yet preventable for patients with type 2 diabetes mellitus (T2DM). Because each patient with T2DM has a different risk of developing cardiovascular complications, the accurate stratification of cardiovascular risk is critical. In this study, we proposed cardiovascular risk engines based on machine-learning algorithms for newly diagnosed T2DM patients in Korea.
Methods
To develop the machine-learning-based cardiovascular disease engines, we retrospectively analyzed 26,166 newly diagnosed T2DM patients who visited Seoul St. Mary’s Hospital between July 2009 and April 2019. To accurately measure diabetes-related cardiovascular events, we designed a buffer (1 year), an observation (1 year), and an outcome period (5 years). The entire dataset was split into training and testing sets in an 8:2 ratio, and this procedure was repeated 100 times. The area under the receiver operating characteristic curve (AUROC) was calculated by 10-fold cross-validation on the training dataset.
Results
The machine-learning-based risk engines (AUROC XGBoost=0.781±0.014 and AUROC gated recurrent unit [GRU]-ordinary differential equation [ODE]-Bayes=0.812±0.016) outperformed the conventional regression-based model (AUROC=0.723± 0.036).
Conclusion
GRU-ODE-Bayes-based cardiovascular risk engine is highly accurate, easily applicable, and can provide valuable information for the individualized treatment of Korean patients with newly diagnosed T2DM.

Citations

Citations to this article as recorded by  
  • A Novel Approach Utilizing Bagging, Histogram Gradient Boosting, and Advanced Feature Selection for Predicting the Onset of Cardiovascular Diseases
    Norma Latif Fitriyani, Muhammad Syafrudin, Nur Chamidah, Marisa Rifada, Hendri Susilo, Dursun Aydin, Syifa Latif Qolbiyani, Seung Won Lee
    Mathematics.2025; 13(13): 2194.     CrossRef
  • Development and validation of a machine learning model for cardiovascular disease risk prediction in type 2 diabetes patients
    Chunming Xu, Fachao Shi, Wenlong Ding, Cunming Fang, Caoyang Fang
    Scientific Reports.2025;[Epub]     CrossRef
  • Practice Primacy: Revisiting the Knowledge–Action Gap in Pro-Environmental Behavior with eXplainable AI
    Xun Yang, Shensheng Chen, Tingting Liu, Junjie Luo, Yuzhen Tang
    Sustainability.2025; 17(21): 9916.     CrossRef
  • PiCCO hemodynamic parameters in cardiogenic shock: prediction of LVEF, NT-proBNP and MACE based on XGBoost machine learning model
    Jieyun You, Tianwen Wei, Yue Yu, Jing Huang, Yuxiao Sun, Wei Guo, Qi Zhang
    Frontiers in Medicine.2025;[Epub]     CrossRef
Close layer
Diabetes, obesity and metabolism
Big Data Articles (National Health Insurance Service Database)
Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study
Joonyub Lee, Hun-Sung Kim, Kee-Ho Song, Soon Jib Yoo, Kyungdo Han, Seung-Hwan Lee, Committee of Big Data, Korean Endocrine Society
Endocrinol Metab. 2023;38(5):525-537.   Published online September 7, 2023
DOI: https://doi.org/10.3803/EnM.2023.1765
  • 6,956 View
  • 151 Download
  • 11 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigated the risk of cause-specific mortality according to glucose tolerance status in elderly South Koreans.
Methods
A total of 1,292,264 individuals aged ≥65 years who received health examinations in 2009 were identified from the National Health Information Database. Participants were classified as normal glucose tolerance, impaired fasting glucose, newly-diagnosed diabetes, early diabetes (oral hypoglycemic agents ≤2), or advanced diabetes (oral hypoglycemic agents ≥3 or insulin). The risk of system-specific and disease-specific deaths was estimated using multivariate Cox proportional hazards analysis.
Results
During a median follow-up of 8.41 years, 257,356 deaths were recorded. Diabetes was associated with significantly higher risk of all-cause mortality (hazard ratio [HR], 1.58; 95% confidence interval [CI], 1.57 to 1.60); death due to circulatory (HR, 1.49; 95% CI, 1.46 to 1.52), respiratory (HR, 1.51; 95% CI, 1.47 to 1.55), and genitourinary systems (HR, 2.22; 95% CI, 2.10 to 2.35); and neoplasms (HR, 1.30; 95% CI, 1.28 to 1.32). Diabetes was also associated with a significantly higher risk of death due to ischemic heart disease (HR, 1.70; 95% CI, 1.63 to 1.76), cerebrovascular disease (HR, 1.46; 95% CI, 1.41 to 1.50), pneumonia (HR, 1.69; 95% CI, 1.63 to 1.76), and acute or chronic kidney disease (HR, 2.23; 95% CI, 2.09 to 2.38). There was a stepwise increase in the risk of death across the glucose spectrum (P for trend <0.0001). Stroke, heart failure, or chronic kidney disease increased the risk of all-cause mortality at every stage of glucose intolerance.
Conclusion
A dose-dependent association between the risk of mortality from various causes and severity of glucose tolerance was noted in the elderly population.

Citations

Citations to this article as recorded by  
  • Glucose tolerance and mortality across 24 cancer types and stages: A K‐CURE Nationwide registry study
    Kyung‐Hun Sung, Jin Yu, Seyoon Kim, Mee Kyoung Kim, Yong‐Moon Mark Park, Kyungdo Han, Seung‐Hwan Lee
    Diabetes, Obesity and Metabolism.2026; 28(3): 2051.     CrossRef
  • Inverse association between obesity and suicidal death risk
    Joonyub Lee, Seung-Hwan Lee, Mee-Kyoung Kim, Hyuk-Sang Kwon, Jae-Seung Yun, Yeoree Yang, Kun-Ho Yoon, Jae-Hyoung Cho, Chi-Un Pae, Kyungdo Han, Jang Won Son
    BMC Psychiatry.2025;[Epub]     CrossRef
  • The growing range of complications of diabetes mellitus
    Peter S. Hamblin, Anthony W. Russell, Stella Talic, Sophia Zoungas
    Trends in Endocrinology & Metabolism.2025; 36(10): 943.     CrossRef
  • The association between new insulin resistance indices and all-cause mortality in elderly patients with diabetes: a prospective cohort study
    Yanling Yang, Zhigu Liu, Beisi Lin, Yintong Huang, Hongrong Deng, Xubin Yang, Longyi Zeng, Jinhua Yan, Wen Xu
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • MOFI-FL, a novel score for detecting hepatic steatosis and predicting cardiometabolic mortality
    Juan Reyes-Barrera, Rosalinda Posadas-Sánchez, Gilberto Vargas-Alarcón, Guillermo C. Cardoso-Saldaña, Paloma Almeda-Valdes, Omar Yaxmehen Bello Chavolla, Luis Ortiz-Hernandez, Neftali Eduardo Antonio-Villa
    Scientific Reports.2025;[Epub]     CrossRef
  • Effect of glucose variability on the mortality of adults aged 75 years and over during the first year of the COVID-19 pandemic
    Miguel A. Salinero-Fort, F. Javier San Andrés-Rebollo, Juan Cárdenas-Valladolid, José Mostaza, Carlos Lahoz, Fernando Rodriguez-Artalejo, Paloma Gómez-Campelo, Pilar Vich-Pérez, Rodrigo Jiménez-García, José M. de-Miguel-Yanes, Javier Maroto-Rodriguez, Bel
    BMC Geriatrics.2024;[Epub]     CrossRef
  • Islet transplantation in Korea
    Joonyub Lee, Kun‐Ho Yoon
    Journal of Diabetes Investigation.2024; 15(9): 1165.     CrossRef
  • All-cause and cause-specific mortality risks in individuals with diabetes living alone: A large-scale population-based cohort study
    Jae-Seung Yun, Kyungdo Han, Bongseong Kim, Seung-Hyun Ko, Hyuk-Sang Kwon, Yu-Bae Ahn, Yong-Moon Mark Park, Seung-Hwan Lee
    Diabetes Research and Clinical Practice.2024; 217: 111876.     CrossRef
  • Changes in the Epidemiological Landscape of Diabetes in South Korea: Trends in Prevalence, Incidence, and Healthcare Expenditures
    Kyoung Hwa Ha, Dae Jung Kim
    Endocrinology and Metabolism.2024; 39(5): 669.     CrossRef
  • Osteoporosis incidence and its associated factors in the older Korean population: findings from a population-based cohort study
    Tanmoy Das, Md Abdullah Al Jubayer Biswas, Prosanta Mondal, Sabuj Sarker, Hyun J.“June” Lim
    Archives of Osteoporosis.2024;[Epub]     CrossRef
  • Income-Related Disparities in Mortality Among Young Adults With Type 2 Diabetes
    Ji Yoon Kim, Sojeong Park, Minae Park, Nam Hoon Kim, Sin Gon Kim
    JAMA Network Open.2024; 7(11): e2443918.     CrossRef
  • The Characteristics and Risk of Mortality in the Elderly Korean Population
    Sunghwan Suh
    Endocrinology and Metabolism.2023; 38(5): 522.     CrossRef
Close layer
Response
Diabetes, Obesity and Metabolism
Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes (Endocrinol Metab 2022;37:641-51, Han-sang Baek et al.)
Han-sang Baek, Ji-Yeon Park, Jin Yu, Joonyub Lee, Yeoree Yang, Jeonghoon Ha, Seung Hwan Lee, Jae Hyoung Cho, Dong-Jun Lim, Hun-Sung Kim
Endocrinol Metab. 2022;37(6):945-946.   Published online December 2, 2022
DOI: https://doi.org/10.3803/EnM.2022.602
  • 4,203 View
  • 177 Download
  • 2 Crossref
PDFPubReader   ePub   

Citations

Citations to this article as recorded by  
  • Young patients with type 2 diabetes have high relative risks for complications in a country with middle-high sociodemographic index, similarly to those countries with high index
    Gergő A. Molnár, Zoltán Kiss, István Wittmann
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Differences in cardiovascular disease incidence according to changes in obesity status in young diabetic patients
    Do Kyeong Song, Yeon-Ah Sung, Young Sun Hong, Min-ho Kim, Hyejin Lee
    Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub]     CrossRef
Close layer
Original Article
Diabetes, Obesity and Metabolism
Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes
Han-sang Baek, Ji-Yeon Park, Jin Yu, Joonyub Lee, Yeoree Yang, Jeonghoon Ha, Seung Hwan Lee, Jae Hyoung Cho, Dong-Jun Lim, Hun-Sung Kim
Endocrinol Metab. 2022;37(4):641-651.   Published online August 29, 2022
DOI: https://doi.org/10.3803/EnM.2022.1501
  • 12,035 View
  • 243 Download
  • 16 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The prevalence of young-onset diabetes (YOD) has been increasing worldwide. As the incidence of YOD increases, it is necessary to determine the characteristics of YOD and the factors that influence its development and associated complications.
Methods
In this retrospective study, we recruited patients who were diagnosed with type 2 diabetes mellitus between June 2001 and December 2021 at a tertiary hospital. The study population was categorized according to age: YOD (age <40 years), middle-age-onset diabetes (MOD, 40≤ age <65 years), and late-onset diabetes (LOD, age ≥65 years). We examined trends in glycemic control by analyzing fasting glucose levels during the first year in each age group. A Cox proportional-hazards model was used to determine the relative risk of developing complications according to glycemic control trends.
Results
The fasting glucose level at the time of diagnosis was highest in the YOD group (YOD 149±65 mg/dL; MOD 143±54 mg/dL; and LOD 140±55 mg/dL; p=0.009). In the YOD group, glucose levels decreased at 3 months, but increased by 12 months. YOD patients and those with poor glycemic control in the first year were at a higher risk of developing complications, whereas the risk in patients with LOD was not statistically significant.
Conclusion
YOD patients had higher glucose levels at diagnosis, and their glycemic control was poorly maintained. As poor glycemic control can influence the development of complications, especially in young patients, intensive treatment is necessary for patients with YOD.

Citations

Citations to this article as recorded by  
  • Association of Age at Type 2 Diabetes Onset With Diabetes Progression
    Seyedeh Forough Sajjadi, Julian W. Sacre, Agus Salim, Brian Oldenburg, Panniyammakal Jeemon, Kavumpurathu R. Thankappan, Sathish Thirunavukkarasu, Dianna J. Magliano, Jonathan E. Shaw
    Diabetes Care.2026; 49(1): 118.     CrossRef
  • Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers
    Jaejun Lee, Dong Yeup Lee, Jae Hyeop Jung, Eunkyoung Bae, Jeong A. Yu, Hyun Yang
    Journal of Physical Activity and Health.2025; 22(3): 323.     CrossRef
  • Association between body mass index and survival after hematopoietic stem cell transplantation
    Han-Sang Baek, Jong Hyuk Lee, Joonyub Lee, Seung-Hwan Lee, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Jae-Ho Yoon
    The Korean Journal of Internal Medicine.2025; 40(4): 645.     CrossRef
  • Increased risk of incident mental disorders in adults with new-onset type 1 diabetes diagnosed after the age of 19: A nationwide cohort study
    Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    Diabetes & Metabolism.2024; 50(1): 101505.     CrossRef
  • Association between age at diagnosis of type 2 diabetes and cardiovascular morbidity and mortality risks: A nationwide population-based study
    Da Hea Seo, Mina Kim, Young Ju Suh, Yongin Cho, Seong Hee Ahn, Seongbin Hong, So Hun Kim
    Diabetes Research and Clinical Practice.2024; 208: 111098.     CrossRef
  • Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus
    Hye-Sun Park, Yongin Cho, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, Young Ju Suh, Suk Chon, Jeong-Taek Woo, Sei Hyun Baik, Kwan Woo Lee, So Hun Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • Early onset type 2 diabetes mellitus: an update
    Myrsini Strati, Melpomeni Moustaki, Theodora Psaltopoulou, Andromachi Vryonidou, Stavroula A. Paschou
    Endocrine.2024; 85(3): 965.     CrossRef
  • The Effect of Glycemic Control on Cardiovascular Disease Progression in Adults With Early-Onset Type 2 Diabetes: A Longitudinal Cohort Analysis
    Amna Gilani, Khalid Umar, Fatima Gilani, Muhammad Ahmad, Mahnoor S Abbasi, Muhammad Yaseen, Muhammad Zeeshan, Naqeeb Ullah, Aiman Waseem, Fatima Batool, Sundas Safdar
    Cureus.2024;[Epub]     CrossRef
  • Complications and Treatment of Early-Onset Type 2 Diabetes
    Fahimeh Soheilipour, Naghmeh Abbasi Kasbi, Mahshid Imankhan, Delaram Eskandari
    International Journal of Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes (Endocrinol Metab 2022;37:641-51, Han-sang Baek et al.)
    Han-sang Baek, Ji-Yeon Park, Jin Yu, Joonyub Lee, Yeoree Yang, Jeonghoon Ha, Seung Hwan Lee, Jae Hyoung Cho, Dong-Jun Lim, Hun-Sung Kim
    Endocrinology and Metabolism.2022; 37(6): 945.     CrossRef
  • ISPAD Clinical Practice Consensus Guidelines 2022: Management of the child, adolescent, and young adult with diabetes in limited resource settings
    Anju Virmani, Stuart J. Brink, Angela Middlehurst, Fauzia Mohsin, Franco Giraudo, Archana Sarda, Sana Ajmal, Julia E. von Oettingen, Kuben Pillay, Supawadee Likitmaskul, Luis Eduardo Calliari, Maria E. Craig
    Pediatric Diabetes.2022; 23(8): 1529.     CrossRef
  • Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes (Endocrinol Metab 2022;37:641-51, Han-sang Baek et al.)
    May Thu Hla Aye, Sajid Adhi Raja, Vui Heng Chong
    Endocrinology and Metabolism.2022; 37(6): 943.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP